AIM

#5054
AIM ImmunoTech Inc.
0.5279 USD
-8.98%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
0.5277
0.5279
Rango anual
0.5060
20.3500
Cambio diario
-8.98%
Variación mensual
-29.61%
Variación en los últimos 6 meses
-80.38%
Cambio anual
-93.79%
Cierres anteriores
0.5800
Abrir
0.5277
Bid
Ask
Mínimo
0.5277
High
0.5279
Volumen
4
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

AIM ImmunoTech Inc

AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida that is focused on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Founded in 1990, the company has twenty-three employees. The company has created an immunomodulatory double stranded RNA drug called Ampligen. It is also developing Ampligen to use as a treatment for multiple cancer tumor types, COVID-19 and chronic fatigue syndrome.

Noticias